Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Glioma × Tranexamic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Hemorrhage 5 Hematologic Neoplasms 3 Head and Neck Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Postoperative Complications 1 Myofibroma 1 Metrorrhagia 1 Meningioma 1 Melanoma 1 Leiomyoma 1 Glioma 1 Astrocytoma 1

Interventions

Temozolomide 6 Radiotherapy 6 Lomustine 5 Procarbazine 4 Bevacizumab 4 Vincristine 3 Carmustine 3 vorasidenib 1 contrast agent BR1 1 carmustine, poliferprosan 20 drug combination 1 Valproic Acid 1 Tranexamic Acid 1 TIC10 compound 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Microbubbles 1 Isotretinoin 1 IL13-PE38 1 Fentanyl 1 Eflornithine 1 Donepezil 1 Dihematoporphyrin Ether 1 Dianhydrogalactitol 1 Dexamethasone 1 Dalteparin 1 Chemotherapy, Adjuvant 1 Aminolevulinic Acid 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01655927 2012-08-02

COLFIRE

Colombian Foundation for Epilepsy and Neurological Disease

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioma, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡